The effect of initial serum neuron-specific enolase level on clinical outcome in acute carotid artery territory infarction

Yonsei Medical Journal

Volumn 43, Issue 3, 2002, Pages 357-362

  Oh, Seung Hun ^a   Lee, Jin Goo ^a   Na, Sang Jun ^a   Park, Ji Hyung ^a   Kim, Won Joo ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Cerebral infarction; Neuron specific enolase (NSE); Prognosis

Indexed keywords

BIOLOGICAL MARKER; BRAIN ENZYME; NEURON SPECIFIC ENOLASE;

ADULT; AGE; AGED; ARTICLE; BRAIN CORTEX; BRAIN INFARCTION; BRAIN INJURY; CAROTID ARTERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; RATING SCALE; STROKE; WHITE MATTER;

EID: 0036309438     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2002.43.3.357     Document Type: Article

References (32)

1. Neuron-specific enolase, a clinically useful marker for neurons and neuroendocrine cells
2. Brain enolase as specific marker of neuronal and glial cells
3. Serum neuron-specific enolase, carnosinase, and their ratio in acute stroke: An enzymatic test for predicting outcome?
4. Serum neuron-specific enolase as an indicator of stroke volume
5. Serum neuron-specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarction
6. Leakage of brain-originated proteins in peripheral blood: Temporal profile and diagnostic value in early ischemic stroke
7. Cerebrospinal fluid enolase in stroke
8. Levels of serum and cerebrospinal fluid enolase in patients with cerebral vascular disease and other neurological disease
9. S-100 protein and neuron-specific enolase concentration in blood as indicators of infarction volume and prognosis in acute ischemic stroke
10. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: Markers of cell damage in human central nervous system
11. Enolase isoenzymes in the cerebrospinal fluid of patients with diseases of the nervous system
12. Neuronspecific enolase concentrations in blood as a prognostic parameter in cerebrovascular disease
13. Neuron-specific enolase and N-acetyl-aspartate as potential peripheral markers of ischemic stroke
14. Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage
15. Neuron-specific enolase increases in cerebral and systemic circulation following focal ischemia
16. CSF neuron-specific enolase as a quantitative marker of neuronal damage in a rat stroke model
17. S-100 protein and neuron-specific enolase in CSF after experimental traumatic or focal ischemic brain damage
18. Neuron-specific enolase is a marker of cerebral ischemia and infarct size in rat cerebrospinal fluid
19. Neuron-specific enolase in gerbil brain and serum after transient cerebral ischemia
20. Experimental brain ischemia: Neuron-specific enolase level in cerebrospinal fluid as an index of neuronal damage
21. Protein S-100B and neuron-specific enolase as early neurobiochemical markers of the severity of traumatic brain injury
22. Comparison of serial S-100 and NSE serum measurements after severe head injury
23. Neurological outcome after out-of-hospital cardiac arrest-prediction by cerebrospinal fluid enzyme analysis
24. Markers of cerebral ischemia after cardiac surgery
25. Status epilepticus increases CSF levels of neuron-specific enolase and alters the blood-brain barrier
26. Serum neuron-specific enolase in the major subtype of status epilepticus
27. Serum neuron-specific enolase in human status epilepticus
28. Measurement of acute cerebral infarction: A clinical examination scale
29. Cerebral vascular accidents in patients over the age of 60, II: Prognosis
30. Increased serum neuron-specific enolase concentrations in patients with hyperglycemic cortical ischemic stroke
31. Biochemical markers in acute ischemic stroke
32. Serum S100-b and neuron specific enolase (NSE) in acute ischemic stroke